Xcelience to expand headquarters in Tampa, Florida, US
Will create 100 new jobs and invest more than US$9m
Xcelience, an international contract development and manufacturing organisation (CDMO) servicing the pharmaceutical and biotechnology industries, is expanding its product development services and manufacturing operations in Tampa, Florida, US, creating 100 new jobs in the process.
The company will also invest US$9m in the region as part of the expansion.
Xcelience will increase capacity in its manufacturing facilities with a 6,000ft2 (around 560m2) expansion at its 5415 W. Laurel Street location. The company will also expand its pharmaceutical development labs in a new 71,000ft2 headquarters at 4910 Savarese Circle in Tampa to support future company growth.
The new jobs will include staff for pharmaceutical development, manufacturing, quality assurance and packaging, the company said.
Derek Hennecke, President & CEO of Xcelience, said: 'Tampa is a great place to build a base of scientific capabilities. Our location puts us just a mile from the airport, making it easy for out of state clients to find us. Exciting things are coming down the pipeline for Tampa, for Xcelience, and the exciting new medical treatments we are developing with our clients.'
Xcelience provides preformulation, formulation development, analytical services, GMP manufacturing, small-scale commercial manufacturing, and global clinical supplies packaging and logistics to help companies move a drug into clinical trials.
Xcelience joins an increasing number of life sciences and manufacturing industry companies that have decided to expand in Tampa and Hillsborough County, including Bristol-Myers Squibb, Covidien, HealthPlan Services, Synergy Health, Smart Science Labs, and LifeLink.
